THE BioMed Co., Ltd. (KOSDAQ:214610)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,540.00
+25.00 (0.55%)
At close: Sep 18, 2025

THE BioMed Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-24,688-30,849-25,774-38,893-10,575-5,776
Upgrade
Depreciation & Amortization
1,4902,0852,3102,8472,4391,776
Upgrade
Loss (Gain) From Sale of Assets
-337.03-313.83-2,063192.280.55-
Upgrade
Asset Writedown & Restructuring Costs
848.89848.89739.181,078-48.08
Upgrade
Loss (Gain) From Sale of Investments
5,9565,956577.46-5.05--
Upgrade
Loss (Gain) on Equity Investments
--3,2247,769--
Upgrade
Stock-Based Compensation
-111.63290.87---0.04
Upgrade
Provision & Write-off of Bad Debts
129.59285.57341.44,6434,218289.46
Upgrade
Other Operating Activities
8,1568,83312,5008,0861,3229,483
Upgrade
Change in Accounts Receivable
3,5933,425376.454,825-3,878-10,699
Upgrade
Change in Inventory
428.6-878.86-1,114-2,222500.55-14,652
Upgrade
Change in Accounts Payable
1,0881,08595.7512.9-796.421,069
Upgrade
Change in Other Net Operating Assets
-3,203-1,463-2,572-2,340-1,831-217.88
Upgrade
Operating Cash Flow
-6,650-10,696-11,359-14,006-8,600-18,679
Upgrade
Capital Expenditures
-9,018-955.55-385.41-1,625-2,841-5,761
Upgrade
Sale of Property, Plant & Equipment
61.738.395,110223.2-0-
Upgrade
Cash Acquisitions
-1,978-1,978-1,622---
Upgrade
Sale (Purchase) of Intangibles
173170.49-295.88-35.8-289.93-261.49
Upgrade
Investment in Securities
825.2412,952-3,010-11,450-8,876-3,239
Upgrade
Other Investing Activities
58.19-22.9-24.41245.34-7.49-50.34
Upgrade
Investing Cash Flow
-14,8546,107-8,565-12,528-12,595-9,727
Upgrade
Short-Term Debt Issued
-9,000261.08-4,00011,000
Upgrade
Long-Term Debt Issued
-3,000-8,93720,000-
Upgrade
Total Debt Issued
4,95112,000261.088,93724,00011,000
Upgrade
Short-Term Debt Repaid
---6,000---8,000
Upgrade
Long-Term Debt Repaid
--14,084-16,296-666.44-938.28-956.47
Upgrade
Total Debt Repaid
248.15-14,084-22,296-666.44-938.28-8,956
Upgrade
Net Debt Issued (Repaid)
5,199-2,084-22,0358,27123,0622,044
Upgrade
Issuance of Common Stock
10,97810,97845,63656.28671.4237,746
Upgrade
Other Financing Activities
-2.86-0-13.55---
Upgrade
Financing Cash Flow
16,1448,89423,5878,32723,73339,789
Upgrade
Foreign Exchange Rate Adjustments
-180.5214.8311.6474.07418.29-133.61
Upgrade
Net Cash Flow
-5,4684,3193,676-18,1332,95611,250
Upgrade
Free Cash Flow
-15,668-11,652-11,744-15,631-11,441-24,440
Upgrade
Free Cash Flow Margin
-914.72%-251.10%-218.81%-97.02%-37.76%-53.51%
Upgrade
Free Cash Flow Per Share
-3293.80-2671.58-4745.83-7118.61-5220.26-13965.96
Upgrade
Cash Interest Paid
622.221,130360.44646.9646.64253.17
Upgrade
Cash Income Tax Paid
-40.0571.435.161.62-5.33
Upgrade
Levered Free Cash Flow
-3,532-5,049-16,3971,230-9,991-25,843
Upgrade
Unlevered Free Cash Flow
-2,924-4,196-14,4132,746-9,632-25,409
Upgrade
Change in Working Capital
1,9062,168-3,214275.74-6,005-24,500
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.